CDC: peak of 1.625 million people infected with the new coronavirus in the hospital

Read Time:6 Minute, 25 Second

On February 1, the Chinese Center for Disease Control and Prevention (CDC) reported the “national outbreak of novel coronavirus infection”.

Number of positives: Since December 9, 2022, the number of positive nucleic acid tests and positivity rate of the population reported by provinces showed a trend of first increasing and then decreasing, with the number of positives peaking on December 22 (6.94 million) and then gradually decreasing to a low of 15,000 on January 23, 2023, followed by a low fluctuation to 24,000 on January 30.

Overall attendance results: The number of fever outpatient (clinic) visits nationwide (excluding Hong Kong, Macau and Taiwan) peaked at 2.867 million on December 23, 2022, and showed low fluctuations after January 23, 2023, with 164,000 visits on January 30.

Results for new coronavirus infections in hospital: peaked at 1,625,000 on January 5, 2023, then continued to decline, to 144,000 on January 30.

In-hospital neo-coronavirus infection positive severe patient outcomes: the number of severe patients increased by nearly 10,000 per day between December 27, 2022 and January 3, 2023, peaking at 128,000 on January 5 and declining to 14,000 on January 30.

Deaths from new coronavirus infections in the hospital: reached a daily peak of 4,273 on January 4, then continued to decline, dropping to 434 on January 30.

Beijing detected influenza-like cases last week.

New crown positive rate 5.08%

Wang Quan Yi, deputy director of the Beijing CDC, introduced that Beijing has now established temporary population immunization. In order to comprehensively assess the situation of new coronavirus infection and understand the serum antibody level of the community population, Beijing will soon conduct a population serum antibody survey. The survey is scheduled to be completed from February to March this year, and will take a multi-stage stratified random sampling approach, with approximately 5,000 community populations selected from 16 jurisdictions and the Economic Development Zone for questionnaire surveys and serological specimen collection.

According to the sampling and monitoring data of influenza-like cases, in the 4th week of this year (January 23-29), the number of influenza-like cases among the cumulative number of emergency outpatient visits monitored in medical institutions above the second level in Beijing decreased by 40.87% compared with the previous week, 84.53% compared with the same period last year, and 93.74% compared with the peak of this epidemic season. A total of 453 respiratory specimens of influenza-like cases were collected and tested in Beijing, of which 23 were positive for nucleic acid of the new coronavirus, with a positive rate of 5.08% (11.59% in the previous week).

Famous breast surgery specialist Hanyuan Huang passed away

Comrade Huang Hanyuan, a member of the Preparatory Party of the Communist Party of China, a famous breast surgery expert and chief physician of Peking Union Medical College Hospital, died in Beijing on January 31, 2023 at the age of 90 due to medical treatment.

In the 1980s, Huang took the lead in establishing the steroid hormone receptor laboratory for breast cancer in China, laying the foundation for endocrine treatment of breast cancer; and through clinical research, he improved the traditional breast cancer surgery procedure, significantly shortening the surgery time for breast cancer. With his excellent medical skills and rich clinical experience, Hanyuan Huang has completed tens of thousands of breast surgeries.

After his retirement, H.Y. Huang has continued to work in the medical field. In recent years, he has applied glandular flap transfer to the clinical treatment of plasmacytoid mastitis and granulomatous mastitis, creatively integrating surgical treatment with breast reconstruction, and has cured more than 4,000 patients with various types of mastitis. He is still at the operating table at the age of 90, completing dozens of operations every month, and his deeds have been reported by CCTV many times.

Henan: Starting from March 1, the

Adjustment of inpatient consultation fee, abolition of outpatient infusion fee

Recently, the Henan Provincial Medical Security Bureau, Henan Provincial Health and Health Commission issued a “notice on the determination of new and revised medical service price items in 2022” (hereinafter referred to as “Notice”), announced 95 new medical service price items and 160 revised medical service price items, starting from March 1 this year.

The Notice proposes that the 95 new medical service price items, “clinical scale assessment”, spinal cord electrode implantation and other 24 A-class items to determine the price of the provincial public medical institutions, health insurance payment categories and provincial employees health insurance down payment ratio; 71 B-class items, “genetic Metabolic disease detection”, drug concentration measurement and other 49 items to determine the unified trial price, “poisoning drugs and toxic screening” sacral nerve control electrode implantation and other 22 items by medical institutions to determine the trial price.

The revised 160 medical service price items, the “hospital consultation fee” and other 92 medical service price items to adjust the content of the perfect; canceled the “outpatient infusion fee”, malignant tumor deep heat therapy and other 68 medical service price items.

50 people infected with 1 death.

The U.S. Centers for Disease Control urgently called off an eye drop

According to the U.S. “New York Post” reported that the U.S. Centers for Disease Control and Prevention recently called an emergency suspension of an eye drop called “EzriCare” and said it was associated with 50 cases of bacterial infections and one death in 11 states.

Of those infected, most said they had used artificial tears, with “EzriCare” being the brand most frequently mentioned. The CDC is testing the bacteria in the eye drops to see if they match the strains in the infected cases. The CDC is also recommending that clinicians and patients stop using the eye drops immediately until epidemiological investigations and laboratory analyses are completed.

“EzriCare, for its part, said it has not received any consumer complaints or reports of adverse reactions related to the investigation, nor has it received any news from any regulatory agency regarding the investigation, nor has the company been asked to conduct a product recall, but has advised customers to temporarily stop using the product in question.

Zheng University First Affiliated Hospital responds to rumors that a new campus will be built: true

On February 1, a news about “the First Affiliated Hospital of Zhengzhou University will build a new campus” circulated in the network. Yesterday afternoon, Zhengzhou City, Zhongyuan District, a staff member said that the project was previously in the demonstration stage, what stage is currently underway is not clear. And a staff member of the First Affiliated Hospital of Zhengzhou University said that the incident is true. The search found that the official website of the First Affiliated Hospital of Zhengzhou University has issued several announcements related to this.

Octogenarian donates more than 70,000 pensions to hospital

On the morning of January 31, an old man with white hair, carrying a black plastic bag, came to the entrance of the office of Dongyang People’s Hospital. “I want to donate!” The old man said. The old man is 83 years old, he does not want to reveal his name: “the epidemic that I would like to donate, the medical staff are good. Today I came to the hospital to get my medicine, so I decided to take this opportunity to donate.” The old man’s behavior also made the hospital staff very admirable, but considering that the old man is old and needs money for his own life, he was discouraged to take the money back. Despite much discouragement, the old man still wanted to donate the money to the hospital.